All News

A string of thefts at local pharmacies has spurred the DEA to issue warnings and share tips for independent pharmacists to keep their stores secure.

See what's trending in pharmacy with a preview of the Total Pharmacy April issue.

In the United States, 12 million adults suffer from co-occurring chronic pain and anxiety or depression. Erasing stigmas, educating patients, and tailoring interventions can help to improve outcomes.

Drug Topics sat down with Sally Rafie, founder of Birth Control Pharmacist, to discuss how pharmacists are well positioned to expand access to reproductive care.

Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.

After a long hiatus, research in psychedelic medicine is progressing rapidly. With the potential approval of MDMA in the near future, what role will pharmacists play in integrating these new therapies into treatment plans?

Since a 2019 measles outbreak, the CDC has seen an increasing number of cases in the US.

Although over 38 million people in the US have diabetes, continuous glucose monitor (CGM) uptake is low. Community pharmacists are uniquely positioned to promote uptake due to their frequent interactions with patients and expertise in chronic condition counseling.

The CDC addressed an HPAI A(H5N1) virus infection reported by a commercial dairy farmer in Texas.

“Every pharmacist raises their hand and takes an oath before they graduate to put patients first,” said Bruce Berger, PhD, FAPhA. “But what happens when you exist in an environment every single day where that’s impossible?”

Japan’s health ministry has issued a warning to consumers regarding red yeast rice dietary supplements containing a red species of mold after 5 people died and more were hospitalized after consumption.

See what's trending in pharmacy with a preview the Drug Topics April issue.

Researchers addressed pharmacists’ role in mitigating drug shortages.

Due to the increased possibility of adverse pregnancy outcomes associated with methotrexate and leflunomid, it is crucial that patients with rheumatoid arthritis (RA) engage in thorough consultations with their physicians regarding pregnancy planning.

Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.

With drug price negotiations for 10 drugs through the Inflation Reduction Act (IRA) set to take effect in 2026, researchers simulated the extent of Medicare savings.

In 4 posters presented at the Hematology/Oncology Pharmacy Association Annual Conference 2024, researchers addressed pharmacists’ role in managing patients’ anticancer medications.

Vistagen has enrolled the first participant in the PALISADE-3 phase 3 trial of fasedienol for the treatment of social anxiety disorder.

The drug was previously approved in 2009 to treat schizophrenia.

It can be hard to look away from a once in a lifetime total eclipse, but it’s important to understand the risks that come with viewing.

This year’s conference, which is being held April 4 to 6 in San Diego, California, features talks from industry experts on developments in the pharmacy field, actionable skills, and informative CE sessions.

Priovant Therapeutics said that it intends to initiate a phase 3 program of brepocitinib in the second half of this year.

Rejoyn from Otsuka Pharmaceutical and Click Therapeutics is a 6-week program that helps enhance cognitive control of emotions through brief therapy lessons and training exercises.

In comparison with the traditional volume-based pharmacy model, the membership model decreases financial barriers while increasing customer-pharmacist relationships.

The can’t-miss event on April 13 features speakers and CE sessions focused on elevating patient-centric care.

According to Anita Jacobson, PharmD, pharmacists should actively facilitate access to harm reduction programs by providing information and resources, ensuring the person who uses drugs doesn’t have to navigate the landscape on their own.

It’s important that pharmacists continuously revise their counseling as new information about substances such as xylazine, levamisole, and phenacetin emerges, said Anita Jacobson at this year’s American Pharmacists Association Annual Meeting & Exposition.

Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.